[HTML][HTML] Spinal movement disorders in NMOSD, MOGAD, and idiopathic transverse myelitis: a prospective observational study

H Abboud, R Sun, N Modak, M Elkasaby, A Wang… - Journal of …, 2024 - Springer
Background Retrospective studies suggest that spinal movement disorders, especially tonic
spasms, are prevalent in NMOSD. However, there have been no prospective studies …

The landscape of PBMCs in AQP4‐IgG seropositive NMOSD and MOGAD, assessed by high dimensional mass cytometry

M Yao, W Wang, J Sun, T Guo, J Bian… - CNS Neuroscience …, 2024 - Wiley Online Library
Objectives Data on peripheral blood mononuclear cells (PBMCs) characteristics of
aquaporin‐4 (AQP4)‐IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and …

[HTML][HTML] Reshaping neuroimmunology: diagnosis and treatment in the era of precision medicine

GR Dos Passos, T Adoni, MF Mendes… - Arquivos de Neuro …, 2023 - SciELO Brasil
Precision medicine has revolutionized the field of neuroimmunology, with innovative
approaches that characterize diseases based on their biology, deeper understanding of the …

Navigating through the recent diagnostic criteria for MOGAD: challenges and practicalities

O Ciccarelli, AT Toosy, A Thompson, Y Hacohen - Neurology, 2023 - AAN Enterprises
International criteria for the diagnosis of myelin oligodendrocyte glycoprotein–associated
disease (MOGAD) were published in The Lancet Neurology® on January 24, 2023.1 The …

[HTML][HTML] Clinical Usefulness of a Cell-based Assay for Detecting Myelin Oligodendrocyte Glycoprotein Antibodies in Central Nervous System Inflammatory Disorders

JM Seok, P Waters, MY Jeon, HL Lee… - Annals of laboratory …, 2024 - synapse.koreamed.org
Background The clinical implications of myelin oligodendrocyte glycoprotein autoantibodies
(MOG-Abs) are increasing. Establishing MOG-Ab assays is essential for effectively treating …

Myelin oligodendrocyte glycoprotein antibody and N-methyl-d-aspartate receptor antibody overlapping syndrome: insights from the recent case reports

BQ Du, QL Lai, EC Li, MT Cai, GL Fang… - Clinical and …, 2024 - academic.oup.com
The overlapping of two or more types of neural autoantibodies in one patient has
increasingly been documented in recent years. The coexistence of myelin oligodendrocyte …

[HTML][HTML] Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing

A Budhram, DL Rotstein, L Yang, EA Yeh - Frontiers in Neurology, 2024 - frontiersin.org
Introduction In January 2023, our laboratory began performing serum myelin
oligodendrocyte glycoprotein antibody (anti-MOG) titers by fixed cell-based assay (CBA). As …

Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy

MM Andzelm, CM Stredny - Rheumatic Disease Clinics, 2023 - rheumatic.theclinics.com
Although first proposed over a century ago, 1, 2 in the past few decades, there has been an
increasing appreciation of the role of the immune system and inflammation in a Program in …

Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody …

N Molazadeh, T Akaishi, G Bose, S Nishiyama… - Multiple Sclerosis and …, 2023 - Elsevier
Objectives To determine whether progression independent of relapse activity (PIRA) is
present in Aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder (AQP4+ …

Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD

MR Brier, B Xiang, JR Ciotti, S Chahin, GF Wu… - Multiple sclerosis and …, 2023 - Elsevier
Background Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is
a distinct central nervous system (CNS) disorder that shares features with multiple sclerosis …